The present invention relates to tetrahydronaphthyridine derivatives of the general formula (I): 1 or of the general formula (I') 2 in which A and R.sup.1 are as defined within, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, including the treatment diseases mediated by H3 ligands, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

 
Web www.patentalert.com

< 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyr- idazin-3-one salts and their preparation

< Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders

> 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors

> Novel human seven transmembrane proteins and polynucleotides encoding the same
~ 00221